Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials

Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials

Roy Freeman,1 Birol Emir,2 Bruce Parsons2 1Autonomic and Peripheral Nerve Laboratory, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Pfizer Inc, New York, NY, USABackground: Greater understanding of factors associated with the high placebo-response rates noted in re...

Full description

Bibliographic Details
Main Authors:	Freeman R, Emir B, Parsons B
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	Journal of Pain Research
Online Access:	http://www.dovepress.com/predictors-of-placebo-response-in-peripheral-neuropathic-pain-insights-peer-reviewed-article-JPR

Similar Items

Improvement in pain severity category in clinical trials of pregabalin
by: Parsons B, et al.
Published: (2016-10-01)

Clinical use of pregabalin in the management of central neuropathic pain
by: Nanna B Finnerup, et al.
Published: (2007-01-01)

Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
by: Serpell M, et al.
Published: (2017-07-01)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
by: Martinez Jose A, et al.
Published: (2012-01-01)

The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
by: Parsons B, et al.
Published: (2019-03-01)

Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover study
by: Jenkins TM, et al.
Published: (2012-07-01)

A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
by: A Srivastava, et al.
Published: (2012-01-01)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
by: Le Trong, et al.
Published: (2009-02-01)

Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study
by: Crawford ME, et al.
Published: (2016-05-01)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
by: Yurong Ma, et al.
Published: (2022-06-01)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
by: Şule Karabulut Gül, et al.
Published: (2020-03-01)

Pregabalin and other antiepileptic drugs in chronic neuropathic pain
by: Paolo Marchettini
Published: (2017-05-01)

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
by: Onakpoya, I, et al.
Published: (2019)

Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
by: Paolo Marchettini, et al.
Published: (2005-05-01)

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
by: Zlateva Gergana, et al.
Published: (2010-11-01)

Response to pregabalin and progesterone differs in male and female rat models of neuropathic and cancer pain
by: Robert G. Ungard, et al.
Published: (2020-01-01)

Preclinic and clinic effectiveness of gabapentin and pregabalin for treatment of neuropathic pain in rats and diabetic patients
by: Slavina Surcheva, et al.
Published: (2017-05-01)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
by: Yohei Shimada, et al.
Published: (2017-01-01)

Effect of Gabapentin and Pregabalin in Rat Model of Taxol Induced Neuropathic Pain
by: A.Mangaiarkkarasi, et al.
Published: (2015-05-01)

Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
by: Parsons B, et al.
Published: (2015-06-01)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin
by: Enomoto H, et al.
Published: (2018-09-01)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
by: Huygen F, et al.
Published: (2020-10-01)

Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial
by: Malin E. Carmland, et al.
Published: (2019-10-01)

A meta-epidemiological study on the reported treatment effect of pregabalin in neuropathic pain trials over time.
by: Emma T L Cheng, et al.
Published: (2023-01-01)

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
by: LaMoreaux Linda, et al.
Published: (2008-09-01)

Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
by: Dongre YU, et al.
Published: (2013-05-01)

A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
by: Torrades Sandra, et al.
Published: (2011-01-01)

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.
by: Straube, S, et al.
Published: (2008)

Comparing pregabalin and gabapentin for persistent neuropathic pain: A protocol for a pilot N-of-1 trial series
by: Guy Bashford, et al.
Published: (2021-12-01)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
by: Budhia Sangeeta, et al.
Published: (2010-11-01)

Injection of ropivacaine combined with pregabalin in a patient with post-traumatic trigeminal neuropathic pain
by: Tisné-Versailles Sophie, et al.
Published: (2018-12-01)

Neuropathic Pain Creates Systemic Ultrastructural Changes in the Nervous System Corrected by Electroacupuncture but Not by Pregabalin
by: Gao L, et al.
Published: (2021-09-01)

Peripheral mechanisms of peripheral neuropathic pain
by: Paola Pacifico, et al.
Published: (2023-09-01)

Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin
by: Takuya Yamanaka, et al.
Published: (2023-03-01)

A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin
by: Zin, Che Suraya, et al.
Published: (2010)

Toward Composite Pain Biomarkers of Neuropathic Pain—Focus on Peripheral Neuropathic Pain
by: Monica M. Diaz, et al.
Published: (2022-05-01)

Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats
by: Nariman Essmat, et al.
Published: (2023-08-01)

Preclinical Evaluation of Polymeric Nanocomposite Containing Pregabalin for Sustained Release as Potential Therapy for Neuropathic Pain
by: Rafaela Figueiredo Rodrigues, et al.
Published: (2021-11-01)

The effectiveness of pregabalin with or without agomelatine in the treatment of chronic low back pain: a double-blind, placebo-controlled, randomized clinical trial
by: Seyed Mani Mahdavi, et al.
Published: (2022-09-01)

Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study
by: Guy H. Hans, et al.
Published: (2023-01-01)